Evidence map›Paper›PMID 40438610›Full record

ArticleNAR genomics and bioinformatics2025

IEIVariantFilter: a bioinformatics tool to speed up genetic diagnosis of inborn errors of immunity patients.

Juan Pereda, Rafael Espinosa, Blanca García-Solís, Teresa Guerra-Galán, Ana Van-Den-Rym, Meltem Ece Kars, Rocío Mena, Victor Galán, Ana de Andrés-Martín, Carlos Rodríguez-Gallego and 11 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juan PeredaTECH ID Solutions, Madrid 28049, Spain.
Rafael EspinosaTECH ID Solutions, Madrid 28049, Spain.
Blanca García-SolísLaboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.
Teresa Guerra-GalánClinical Immunology Department, San Carlos Clinical Hospital, Madrid 28040, Spain.
Ana Van-Den-RymLaboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.
Meltem Ece KarsThe Charles Bronfman Institute for Personalized Medicine and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Rocío MenaInstitute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid 28046, Spain.
Victor GalánTranslational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.ORCID https://orcid.org/0000-0002-2682-9664
Ana de Andrés-MartínDepartment of Immunology, Ramón y Cajal Hospital, Madrid 28034, Spain.
Carlos Rodríguez-GallegoDepartment of Immunology, University Hospital of Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria 35010, Spain.
Alberto López-LeraIdiPAZ Institute for Health Research, La Paz University Hospital, CIBERER U-754, Madrid 28046, Spain.
Fernando CorvilloIdiPAZ Institute for Health Research, La Paz University Hospital, CIBERER U-754, Madrid 28046, Spain.
Antonio Pérez-MartínezTranslational Research in Paediatric Oncology, Haematopoietic Transplantation and Cell Therapy, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.
Eduardo López-CollazoInnate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.
Silvia Sánchez-RamónInterdepartmental Group of Immunodeficiencies, Madrid, Spain.
Rubén Martínez-BarricarteDivision of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
Lluis Quintana-MurciUnit of Human Evolutionary Genetics, Institut Pasteur and CNRS URA3012, Paris 75015, France.
José Miguel Lorenzo-SalazarCIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0002-5135-2861
Yuval ItanThe Charles Bronfman Institute for Personalized Medicine and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Carlos FloresCIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0001-5352-069X
Rebeca Pérez-de-DiegoLaboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid 28046, Spain.ORCID https://orcid.org/0000-0001-8426-8765

Funding

The role of SERPINB1 in T cell function and its contribution to human diseasesR01AI168210 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ruben Martinez Barricarte · 2023 to 2026
$2.6M
Gain-of-function complement activators as a new class of immunotherapeutic moleculesR01CA269217 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ruben Martinez Barricarte · 2023 to 2026
$2.0M
Genetic and immunological dissection of isolated NocardiosisR21AI171466 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARTINEZ BARRICARTE, RUBEN · 2022 to 2023
$476k
NCI NIH HHS R01 CA269217NIAID NIH HHS R01 AI168210NIAID NIH HHS R21 AI171466
6 · The paper itself

Abstract

Severe infectious diseases remain the leading cause of death in children and young adults worldwide. Monogenic inborn errors of immunity (IEIs) are traditionally defined as a heterogeneous group of rare inborn genetic diseases affecting the functioning of the immune system. Greater awareness has led to the clinical definition of 485 monogenic IEIs and whole exome sequencing (WES) is becoming increasingly relevant for IEI genetic diagnosis. The current protocol for IEI genetic studies includes manual filtering of the list of genes obtained as a WES read-out providing a short list of candidate genes. This procedure is time-consuming and can produce mistakes due to human error in manual filtering. IEIVariantFilter is a new web-based bioinformatics tool to speed up and refine the genetic diagnosis of IEI patients oriented for users in the biomedical field without needing bioinformatics expertise. IEIVariantFilter prioritizes genetic variants based on ranges of zygosity, the quality of reads, the predicted variant effect, and genes related to immunity, considering a consanguineous hypothesis whenever necessary. IEIVariantFilter facilitates gene and variant list prioritization, speeding up the identification of candidate disease-causing variants for validation by experimental studies. The software improves the genetic diagnosis of patients, thereby facilitating precision medicine and fast and proper treatment.

Indexed as

Computational BiologyGenetic Diseases, InbornImmune System DiseasesSoftwareExome SequencingHumans

Identifiers

PMID40438610
PMCPMC12117399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.